Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.110
-0.020 (-1.77%)
At close: Sep 18, 2026, 4:00 PM EDT
1.120
+0.010 (0.90%)
After-hours: Sep 18, 2026, 4:10 PM EDT
Pliant Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
49
Market Cap
68.73M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.58M | -8.11M | -83.69% |
| Dec 31, 2022 | 9.69M | 2.11M | 27.91% |
| Dec 31, 2021 | 7.57M | -34.25M | -81.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Champions Oncology | 60.66M |
| Gossamer Bio | 53.29M |
| Spero Therapeutics | 47.00M |
| Alps Group | 3.74M |
| Alterity Therapeutics | 2.50M |
| RenovoRx | 1.98M |
PLRX News
- 4 weeks ago - Pliant Therapeutics receives Fast Track designation from FDA for PLN-101095 - TheFly
- 4 weeks ago - Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors - GlobeNewsWire
- 4 weeks ago - Pliant Therapeutics reports Q2 EPS (36c), consensus (34c) - TheFly
- 5 weeks ago - Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 5 weeks ago - Pliant Therapeutics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Pliant Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D. - GlobeNewsWire
- 4 months ago - Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire